Micro Emerging Active

JNJ ICOTYDE Tedavi İçin Sedef Psoriasis Plağı Tedavisinde Umut Vaat Etmektedir

New narrative with limited coverage — still forming.

Puan
0,3
Hız
▲ 0,0
Makaleler
1
Kaynaklar
1

Sentiment Timeline

Event Timeline

Mar 28, 2026
Johnson & Johnson Reports Strong Long-Term Results For ICOTYDE In Plaque Psoriasis Neutral

İlgili Makaleler

Johnson & Johnson Reports Strong Long-Term Results For ICOTYDE In Plaque Psoriasis

Nasdaq · Mar 28, 2026
Mixed

Zaman Çizelgesi

İlk GörülmeMar 28, 2026
Son GüncellemeMar 28, 2026